GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Reliv International RELV · USD

Consumer Staples · US listing · 🇺🇸 United States

Compare

1.79

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Reliv International

Its shares trade under the ticker RELV. It has been listed since 8 March 1993. In the fiscal year to 31 December 2025, it reported revenue of $20.5m and a net loss of $1.6m. At that date it held total assets of $10.6m and shareholders' equity of $6.5m.

Reliv' International, Inc. engages in the development, manufacture, and marketing of a proprietary line of nutritional supplements. The company is headquartered in Chesterfield Missouri, Missouri. The firm sells its products through an international network marketing system using independent distributors. The firm operates through a network marketing segment consisting of six operating units that sell nutritional and dietary products to a sales force of independent distributors that sell the products directly to customers. Its products include Reliv Now with Soy; FibRestore; Innergize! Go; LunaRich; ReversAge; Reliv Now for Kids; Arthaffect; ProVantage; SoySentials; CardioSentials; Reliv Defense; RLV Hemp Full Spectrum 750, and others. Its geographic region includes the United States, Australia/New Zealand, Canada, Mexico, Europe and Asia. Its subsidiaries include Reliv, Inc., Reliv World Corporation, Reliv Australia Pty, Limited, Reliv Now de Mexico, S. de R.L. de C.V. and others.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Personal Care Products
Listed since
8 Mar 1993
Website
reliv.com ↗

Leadership

Pay as last reported

  • Mr. Robert MontgomeryChairman of the Board, since 1985$702,561
  • Mr. Ryan MontgomeryPresident, Chief Executive Officer$293,854
  • Dr. Carl HastingsVice Chairman of the Board, Chief Scientific Officer, since 1990$388,203
  • Mr. Steven AlbrightChief Financial Officer, Senior Vice President$270,352
  • Mr. R. Scott MontgomeryPresident of Operations and International$269,335
  • Mr. Thomas PinnockPresident of Sales and Marketing, since 1992
  • Ms. Debra HellwegChief Operating Officer, Senior Vice President
  • Steven HastingsExecutive Vice President - Sales and Marketing$318,939
  • Mr. Stephen MerrickSenior Vice President, General Counsel, Secretary, since 1989$236,000
  • Mr. Kurt WulffSenior Vice President - Marketing
  • Mr. Jim LahmVice President - Information Technology
  • Robert HenryIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Reliv Now with Soy is a key product in the US market for nutritional supplements.
  • Reliv Now for Kids targets the growing children's health segment in North America.
  • Reliv Defense provides a strong presence in the health care industry across Europe.

Weaknesses

  • Reliv Australia Pty Limited operates in a competitive market in Australia/New Zealand.
  • Reliv Now de Mexico, S. de R.L. de C.V. faces challenges in the Mexican market segment.
  • Reliv World Corporation has limited presence in the Asian market region.

Opportunities

  • Reliv Now with Soy can expand into the European dietary product market segment.
  • Reliv Defense offers growth potential in the health care industry across Asia.
  • Reliv Now for Kids has opportunity in the North American children's health market.

Threats

  • Reliv Australia Pty Limited faces competition in the Australian health care sector.
  • Reliv Now de Mexico, S. de R.L. de C.V. encounters market saturation in Mexico.
  • Reliv World Corporation must address regulatory challenges in the European market.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.